Cargando…
Ovarian reserve in premenopausal women with breast cancer
BACKGROUND: As a special reproductive hormone and ovarian reserve indicator, the role of anti-Müllerian hormone (AMH) in premenopausal women with breast cancer deserves further study. METHODS: We conducted an in-depth analysis of the data from the EGOFACT study (NCT02518191), a phase Ⅲ, randomized,...
Autores principales: | Zong, Xiangyun, Yu, Yang, Chen, Wenhu, Zong, Weiwei, Yang, Hongjian, Chen, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194452/ https://www.ncbi.nlm.nih.gov/pubmed/35691250 http://dx.doi.org/10.1016/j.breast.2022.05.009 |
Ejemplares similares
-
GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Li, Xiaolin, et al.
Publicado: (2021) -
Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021) -
Can Anti-Müllerian Hormone Be a Reliable Biomarker for Assessing Ovarian Function in Women Postchemotherapy?
por: Li, Xiaolin, et al.
Publicado: (2020) -
Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer
por: Park, Woo-Chan
Publicado: (2016) -
Inclusion of premenopausal women in breast cancer clinical trials
por: Corrigan, Kelsey L., et al.
Publicado: (2022)